Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Minerva Surgical, Inc. (UTRS)

0.2101   -0.016 (-6.91%) 03-24 15:59
Open: 0.21 Pre. Close: 0.2257
High: 0.2199 Low: 0.2
Volume: 137,547 Market Cap: 37(M)

Technical analysis

as of: 2023-03-24 4:30:59 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.41     One year: 0.52
Support: Support1: 0.2    Support2: 0.16
Resistance: Resistance1: 0.35    Resistance2: 0.44
Pivot: 0.24
Moving Average: MA(5): 0.22     MA(20): 0.26
MA(100): 0.27     MA(250): 1.4
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 11.3     %D(3): 16.4
RSI: RSI(14): 36.2
52-week: High: 4.65  Low: 0.15
Average Vol(K): 3-Month: 1,853 (K)  10-Days: 212 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ UTRS ] has closed above bottom band by 13.4%. Bollinger Bands are 38.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.22 - 0.22 0.22 - 0.22
Low: 0.2 - 0.2 0.2 - 0.2
Close: 0.21 - 0.21 0.21 - 0.21

Company Description

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Headline News

Fri, 24 Mar 2023
Minerva Surgical, Inc. (NASDAQ:UTRS) Q4 2022 Earnings Call Transcript - Yahoo Finance

Tue, 21 Mar 2023
Minerva Surgical (UTRS) Appoints Kaile Zagger as Chief ... -

Thu, 09 Feb 2023
Minerva Surgical closes $30M financing, has new controlling ... - Mass Device

Thu, 09 Feb 2023
Minerva Surgical Closes $30 Million Private Placement of Common ... - GlobeNewswire

Thu, 26 Jan 2023
Minerva Surgical (UTRS) Stock Surged 68.4% on Investor Interest - AskTraders

Wed, 28 Dec 2022
Minerva Surgical Announces Retirement of CEO David Clapper and ... - GlobeNewswire

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Health Information Services
Shares Out. 30 (M)
Shares Float 10 (M)
% Held by Insiders 6.2 (%)
% Held by Institutions 70.1 (%)
Shares Short 448 (K)
Shares Short P.Month 211 (K)

Stock Financials

EPS -20.73
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -78.55
Profit Margin (%) -34.1
Operating Margin (%) -73.5
Return on Assets (ttm) -27.9
Return on Equity (ttm) 0
Qtrly Rev. Growth 0.6
Gross Profit (p.s.) 1.01
Sales Per Share 1.66
EBITDA (p.s.) -0.87
Qtrly Earnings Growth 0
Operating Cash Flow -31 (M)
Levered Free Cash Flow -39 (M)

Stock Valuations

PE Ratio -0.02
PEG Ratio 0
Price to Book value -0.01
Price to Sales 0.12
Price to Cash Flow -0.21

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.